Central African Republic vs Haiti: Average cost of multi drug-resistant tuberculosis treatment
Central African Republic
1,043 constant 2022 US$
in 2024
Haiti
1,098 constant 2022 US$
in 2024
Central African Republic rank
46th
Haiti rank
44th
Average cost of multi drug-resistant tuberculosis treatment over time
- Central African Republic
- Haiti
How they compare
Haiti currently reports 1,098 constant 2022 US$ against 1,043 constant 2022 US$ in Central African Republic, a difference of 55 constant 2022 US$.
That makes Haiti's figure about 1.1 times Central African Republic's.
The two have swapped places 1 time across 7 shared years of data; in 2017 it was Central African Republic ahead.
Central African Republic ranks 46th and Haiti ranks 44th of 92 countries.
Across the 2 decades both report, Central African Republic averaged higher in 1 and Haiti in 1.
Head to head by decade
| Decade | Central African Republic | Haiti | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,461 constant 2022 US$ | 1,248 constant 2022 US$ | 213.67 constant 2022 US$ | Central African Republic |
| 2020s | 1,080 constant 2022 US$ | 1,673 constant 2022 US$ | 592.75 constant 2022 US$ | Haiti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Central African Republic or Haiti?
- Haiti, at 1,098 constant 2022 US$ against 1,043 constant 2022 US$ in Central African Republic as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Central African Republic and Haiti?
- 55 constant 2022 US$, with Haiti ahead.
- How many years of comparable data are there for Central African Republic and Haiti?
- 7 years are reported by both, from 2017 to 2024.
- How do Central African Republic and Haiti rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Central African Republic ranks 46th and Haiti ranks 44th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.